A Comparative Analysis of 4% Chlorhexidine Versus Methylated Spirit as Prophylaxis of Omphalitis and Sepsis in Newborns
NCT06002295 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2023-08-23
Summary
Introduction: Neonatal sepsis in one of the leading cause of death in developing countries. Umbilical cord care is important as it may lead to infection. Topical treatment can help to reduce the chances of infection as well as increase the chances of early removal. In this regard methylated spirit and chlorhexidine are found to be effective.
Aims and Objectives: To compare the effectiveness of 4% chlorhexidine and methylated spirit in newborns for prevention of omphalitis and neonatal sepsis.
Materials and Methods: This randomized control trial was carried out in neonatal unit of Shaikh Zayed Hospital Lahore. After meeting the inclusion criteria, 300 neonates were enrolled. In group A 4% chlorhexidine was applied for cord care and in group B methylated spirit was used. Neonates were followed till 10th day of life. Careful examination was done for cord separation and for any signs of omphalitis or sepsis. If the neonate had no signs and symptoms of omphalitis and sepsis on 10th day of follow up then it was treatment success.
Conditions
- Neonatal Sepsis
- Omphalitis
Interventions
- DRUG
-
Chlorhexidine Topical Cream
After approval from the hospital ethical committee, neonates fulfilling inclusion and exclusion criteria were selected. Written informed consent was obtained from the parents. Full instructions to avoid confounding variables like maintaining temperature and hygiene of newborn, frequent diaper change, avoidance of herbal tonics and cow milk; are given to mothers. In group "A" 4% chlorhexidine was applied generously over cord along with base of cord stump and surrounding skin thrice a day. In group "B" clean cotton swab dipped in methylated spirit was used to clean cord along with cord clamps and base thrice a day.
- DRUG
-
Methylated Spirit
After approval from the hospital ethical committee, neonates fulfilling inclusion and exclusion criteria were selected. Written informed consent was obtained from the parents. Full instructions to avoid confounding variables like maintaining temperature and hygiene of newborn, frequent diaper change, avoidance of herbal tonics and cow milk; are given to mothers. In group "A" 4% chlorhexidine was applied generously over cord along with base of cord stump and surrounding skin thrice a day. In group "B" clean cotton swab dipped in methylated spirit was used to clean cord along with cord clamps and base thrice a day.
Sponsors & Collaborators
-
Sheikh Zayed Federal Postgraduate Medical Institute
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Day
- Max Age
- 10 Days
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-09-12
- Primary Completion
- 2021-09-22
- Completion
- 2021-11-19
Countries
- Pakistan
Study Locations
More Related Trials
-
Study of Antimicrobial Activity of Omiganan 1% Gel vs. Chlorhexidine 2% for Topical Skin Antisepsis in Healthy Adult Subjects
NCT00608959 ·Status: COMPLETED ·Phase: PHASE3
-
Microbiology, Antimicrobial Resistance and Outcomes of Neonatal Sepsis in China
NCT05089760 ·Status: UNKNOWN
-
Ceftriaxone and Jaundice in Neonates
NCT03133637 ·Status: COMPLETED
-
Role of Antibiotics in Preventing Infection in Babies Born Through Meconium Stained Liquor
NCT01290003 ·Status: COMPLETED ·Phase: NA
-
Management of Early Onset Neonatal Septicaemia: Selection of Optimal Antibacterial Regimen for Empiric Treatment
NCT00487019 ·Status: COMPLETED
-
Antimicrobial Efficacy of 2% CHG (Chlorhexidine Gluconate)
NCT02530541 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Bacterial Decolonization Within Dyads
NCT06541145 ·Status: RECRUITING ·Phase: NA
-
In Vivo Preoperative Skin Preparation Persistence Evaluation
NCT03155178 ·Status: COMPLETED ·Phase: PHASE2
-
Single Dose Ceftriaxone and Metronidazole Versus Multiple Doses for Antibiotic Prophylaxis at Elective Cesarean Section.
NCT02736682 ·Status: COMPLETED ·Phase: PHASE4
-
Antibiotic Therapy for Early Onset Neonatal Sepsis
NCT03932123 ·Status: RECRUITING
-
Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of Age
NCT05856227 ·Status: COMPLETED ·Phase: PHASE3
-
Surgical Site Infection After Episiotomy Repair Related to Routine Use of Antibiotic Prophylaxis in Low-Risk Population
NCT06154720 ·Status: COMPLETED
-
Intravenous and Oral Fosfomycin in Hospitalised Neonates With Clinical Sepsis
NCT03453177 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison Trial for Chloraprep Versus Aqueous Chlorhexidine (2%) for the Prevention of Catheter-related Bacteremia
NCT03489512 ·Status: WITHDRAWN ·Phase: PHASE4
-
Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections
NCT00621192 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Oral Amoxicillin and Cephalexin PK/PD in Neonates
NCT04916951 ·Status: COMPLETED ·Phase: PHASE1
-
Population Pharmacokinetics of Amikacin in Neonates
NCT04867135 ·Status: COMPLETED
-
Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL)
NCT00626795 ·Status: COMPLETED ·Phase: PHASE2
-
In Vivo Patient Preoperative Skin Prep Persistence
NCT02447497 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Controlled Trial Investigating if Antibiotic Use in the First 48 Hours of Life Adversely Impacts the Preterm Infant Microbiome
NCT02477423 ·Status: COMPLETED ·Phase: NA
-
Ampicillin/Sulbactam Versus Cefuroxime as Antimicrobial Prophylaxis for Cesarean Section
NCT01138852 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Trial of Chlorhexidine Gluconate (CHG) Preoperative Skin Preparation
NCT02530554 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Antibiotics for Prevention of SSI in Obese Women Undergoing CS
NCT03736187 ·Status: UNKNOWN ·Phase: NA
-
Effect of an Antiseptic Solution on the Skin Microbiome
NCT05608382 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Antimicrobial Effectiveness of an Antimicrobial Cloth
NCT03229759 ·Status: COMPLETED ·Phase: PHASE2